Shuja Ayouby, DO
Family Practice · Corona
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
Offices
4 locations · Onyx Medical Group Inc · Permanente Medical Group Inc
Hospitals listed: 559657 · 757270 · 757300 · 757407 · 757606 · 751655 · A11533 · B41710. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Ayouby’s office to ask if they take your plan before you enroll.
Original Medicare doctor bills
$11,624
Medicare paid this office $11,624 for 24 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Residence visit for established patient with moderate level of medical decision making, per day at least 40 minutes | 20 | $6,576 | $106 |
| Advance care planning, first 30 minutes | 17 | $1,919 | $69 |
Procedures Medicare counted
| Removal of tissue | 46 | More than 78% of doctors who do this |
Who their Medicare patients are
24 Original Medicare patients in 2024. Average age 71 · Health risk score 2.90. Sicker patients than 9 in 10 peers; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 54% · Depression 54% · COPD 46%.
The office billed $24,865, Medicare allowed $14,376 and paid $11,624; for 113 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 24 | 113 | 71 | 2.90 | $24,865 | $11,624 |
| 2023 | 48 | 327 | 71 | 2.70 | $71,786 | $27,527 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 12 | $10,769 | $87 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 22 | $7,278 | $61 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 28 | $4,142 | $148 |
| New patient visit (60+ min) | 14 | $2,395 | $171 |
| Advance care planning, first 30 minutes | 29 | $1,836 | $61 |
Medicaid work
$1,777 in 2023
Medicaid paid $1,777 for 20 billed services this clinician did in 2023, up to 20 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (60+ min) | 20 | $1,777 |
| 2023 | 20 | 1 | 20 | $1,777 |
Drugs they prescribed that Part D paid
$87,082
Pharmacies billed $87,082 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (12 of 2,235) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
1,692 generic and 509 brand-name prescriptions · $87,082 in drug cost · 506 antibiotic prescriptions to 487 people · 13 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Januvia | 24 | $13,023 | $543 |
| Jardiance | 17 | $10,842 | $638 |
| Eliquis | 17 | $6,303 | $371 |
| Albuterol Sulfate Hfa | 104 | $1,808 | $17 |
| Amoxicillin-Clavulanate Potass | 111 | $1,509 | $14 |
See all 37 drugs
| Januvia | 24 | $13,023 | $543 |
| Jardiance | 17 | $10,842 | $638 |
| Eliquis | 17 | $6,303 | $371 |
| Albuterol Sulfate Hfa | 104 | $1,808 | $17 |
| Amoxicillin-Clavulanate Potass | 111 | $1,509 | $14 |
| Doxycycline Monohydrate | 141 | $1,406 | $10 |
| Prednisone | 132 | $871 | $7 |
| Atorvastatin | 67 | $806 | $12 |
| Azithromycin | 116 | $793 | $7 |
| Nitrofurantoin Mono-Macro | 70 | $645 | $9 |
| Paxlovid (Eua) | 28 | $476 | $17 |
| Metformin | 40 | $447 | $11 |
| Fluticasone Propionate | 25 | $430 | $17 |
| Amlodipine Besylate | 56 | $408 | $7 |
| Losartan | 51 | $398 | $8 |
| Omeprazole | 37 | $363 | $10 |
| Tamsulosin | 22 | $343 | $16 |
| Rosuvastatin | 15 | $329 | $22 |
| Ofloxacin | 11 | $329 | $30 |
| Glipizide | 25 | $327 | $13 |
| Gabapentin | 45 | $302 | $7 |
| Lisinopril | 45 | $267 | $6 |
| Sulfamethoxazole-Trimethoprim | 34 | $221 | $7 |
| Clopidogrel | 23 | $210 | $9 |
| Trazodone | 23 | $182 | $8 |
| Terbinafine | 11 | $157 | $14 |
| Glipizide Er | 13 | $139 | $11 |
| Levothyroxine | 23 | $138 | $6 |
| Escitalopram | 15 | $133 | $9 |
| Montelukast | 13 | $130 | $10 |
| Metoprolol | 13 | $117 | $9 |
| Famotidine | 12 | $104 | $9 |
| Hydrochlorothiazide | 34 | $102 | $3 |
| Donepezil | 17 | $80 | $5 |
| Furosemide | 14 | $71 | $5 |
| Pravastatin | 11 | $48 | $4 |
| Paxlovid | 274 | $0 | $0 |
Year by year
| 2024 | 2,235 | 1,107 | 1% (12) | 23% | $87,082 |
| 2023 | 780 | 202 | 3% (22) | 11% | $37,674 |
| 2022 | 75 | 47 | 0% (0) | None | $2,567 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Eliquis | 14 | $3,184 | $227 |
| Atorvastatin | 61 | $749 | $12 |
| Gabapentin | 24 | $629 | $26 |
| Lisinopril | 40 | $425 | $11 |
| Amlodipine Besylate | 33 | $374 | $11 |
| Levothyroxine | 17 | $359 | $21 |
| Duloxetine | 12 | $330 | $28 |
| Hydrocodone-Acetaminophen | 19 | $305 | $16 |
| Albuterol Sulfate Hfa | 14 | $301 | $21 |
| Losartan | 28 | $279 | $10 |
| Metformin | 28 | $224 | $8 |
| Lisinopril-Hydrochlorothiazide | 16 | $190 | $12 |
| Hydrochlorothiazide | 20 | $178 | $9 |
| Prednisone | 26 | $173 | $7 |
| Rosuvastatin | 13 | $140 | $11 |
| Azithromycin | 18 | $121 | $7 |
| Glipizide | 15 | $117 | $8 |
| Trazodone | 13 | $97 | $7 |
Money from drug and device companies
$51 in 2025
| 2025 | 1 | 3 | None | $51 |
| 2024 | 1 | 5 | None | $111 |
| 2023 | 2 | 2 | None | $35 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Smith+Nephew | Collagenase Santyl | $51 | 3 payments
|
See all 3 published payments
| Smith+Nephew | Meals · 2025-05-27 | Collagenase Santyl | $18 |
| Smith+Nephew | Meals · 2025-03-05 | Collagenase Santyl | $17 |
| Smith+Nephew | Meals · 2025-02-18 | Collagenase Santyl | $16 |
See earlier years (2024, 2023)
2024: $111
| Smith+Nephew | Collagenase Santyl | $111 | 5 payments
|
2023: $35
| Smith+Nephew | Collagenase Santyl | $22 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $13 | 1 payment
|
Professional record
- NPI
- 1134784655
- Trained
- Midwestern University, Chicago College of Osteopathic Med, 2019
- Group
- Onyx Medical Group Inc · Permanente Medical Group Inc
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 3583 Hawthorne Dr, Corona, CA, 92881
- NPI first listed
- 2019-05-09
- NPI last updated
- 2025-02-26
- NPI record certified
- 2025-02-26
This is when the NPI record was last certified, not a medical board exam.